logo_new_en

National projects

Show for type:

All types
1.03 Natural sciences and mathematics / Biology
1.04 Natural Sciences and mathematics/Chemistry
1.04.02 Natural sciences and mathematics / Chemistry / Structural chemistry
1.05 Natural sciences and mathematics/Biochemistry and molecular biology
1.07. Natural sciences and mathematics / Computer intensive methods and applications
1.09 Pharmacy
1-09 Natural sciences and Mathematics - Pharmacy
2.04 Ingeeniring Sciences Technologies / Material Science and Technology
2.05.02 Engineering sciences and technologies/Mechanics/Experimental mechanics
2.06 Engineering sciences and technologies / Systems and cybernetics
2.13 Engineering sciences and technologies / Process engineering
3.00 Medical Sciences
3.01 Medical sciences/ Microbiology and immunology
3.03 Medical sciences/ Neurobiology
3.04 Medical Sciences/Oncology
3.05 Medical sciences / Human reproduction
3.06 Medical sciences / Cardiovascular system
3.07 Medical sciences/Metabolic and hormonal disorders
3.08 Medical Sciences / Public Healt
3.08 Medical Sciences / Public Health
4.00 Biotechnical Sciences
4.01.02 Biotechnical sciences / Forestry, wood and paper technology / Wood technology
4.03 Biotechnical sciences / Plant production
4.04.03 Biotechnical sciences / Veterinarian medicine / Therapy and health prevention of animals
4.06 Biotehniške vede
4.06 Biotechnical sciences / Biotechnology
4.06.01 Biotechnical sciences-Biotechnology-Recombinant DNA technology
4.06.02 Biotechnical sciences / Biotechnology / Bio-engineering
4.06.04 Biotechnical sciences/Biotechnology/Microbe biotechnology

Range:

MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy

Ion channels are now considered unconventional, promising oncological targets, whose expression is often altered in cancer cells and which areemerging as critical players in tumorigenesis. The idea of targeting Kv1.3 ion channels directly in mitochondria, whose function critically depends onion fluxes and which are crucial for both cell survival and apoptosis, could...

01. October 2022 - 30. September 2025 | 1-09 Natural sciences and Mathematics - Pharmacy

Nanofibers for codelivery of selected microbiota cocktails and antimicrobials for local treatment of vaginal infections

Scientific background and problem identification. Vaginal infections are the most common reason women seek medical help and can cause serioushealth consequences, such as pelvic inflammatory disease, increased risk of sexually transmitted infections, and adverse pregnancy outcomes. Themost common vaginal infections are bacterial vaginosis and vaginal candidiasis, bot...

01. October 2022 - 30. September 2025 | 1-09 Natural sciences and Mathematics - Pharmacy

New biofertilization approach based on the microbial multispecies biocatalytic aggregates

Soil quality is decreasing worldwide, due to erosion and intensive use of farmland. Crop plants are not adapted to reduced nutrient content, which is why we need to develop novel soil fertilization approaches delivering nutrients to the vicinity of the roots. In alpine oligotrophic soils mineral-weathering microbes accumulate in “hotspots” in the rhizosp...

01. October 2022 - 30. September 2025 | 4.03 Biotechnical sciences / Plant production

Muscle cell secretom and bone cells interplay in osteosarcopenia (MiKOSA)

Osteosarcopenia (OSA) affects 5-37% of community-dwelling older people (≥65 years) and is diagnosed at even higher rates in people with lowenergy trauma (osteoporotic) bone fractures (7.1–96.3%). There are no diagnostic biochemical markers available and no approved pharmacological agents for treatment of sarcopenia so far. With the present project, we aim t...

01. October 2022 - 30. September 2025 | 3.07 Medical sciences/Metabolic and hormonal disorders

Mechanisms of response to interleukin 12/23 blockers in ulcerative colitis - toward personalized medicine

(slovene) Kljub pomembnemu napredku zdravljenja ulceroznega kolitisa je 30 % pacientov neodzivnih na razpoložljiva zdravila. Ti pacienti trpijo za hudimi simptomi črevesne disfunkcije. Številni potrebujejo operativno odstranitev celotnega debelega črevesa. Ustekinumab, IL 12/23 zaviralec z odličnim varnostnim profilom, je najnovejše zdravilo za zdravlj...

01. October 2022 - 30. September 2025 | 3.01 Medical sciences/ Microbiology and immunology

Next-generation adjuvants for mucosal vaccines

Currently, our world is facing an acute shortage of mucosal vaccine adjuvants. The recent progress in our understanding of innate immunity has opened up new avenues for mucosal vaccine development. The innate immune system is comprised of APCs, in particular dendritic cells (DCs), which contain a series of innate immune receptors. Ligands of these receptors engage D...

01. October 2022 - 30. September 2025 | 3.01 Medical sciences/ Microbiology and immunology

Removal of selected antimicrobials by plasma-cavitation technology from water matrices of varying complexities (Causma)

(slovene) V zadnjem desetletju se je nabralo dovolj dokazov, ki kažejo, da zdravilne učinkovine skozi čistilne naprave nenehno vstopajo v vodno okolje in nanj negativno vplivajo. Težave se še poslabšajo, ko se bolnišnična odpadna voda, ki vsebuje visoke koncentracije različnih protimikrobnih učinkovin, vključno z antibiotiki, spušča nepos...

01. October 2022 - 30. September 2025 | 2.13 Engineering sciences and technologies / Process engineering

Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy

Intracellular targets of the innate immune system that can be modulated by small molecule agents, which offer numerous advantages compared to large biopharmaceuticals, represent big opportunities in pharmacy and innovative possibility to reverse the immune tolerance in the treatment of cancer patients. One of the most important aforementioned targets are Toll-like r...

30. September 2022 - 30. September 2025 | 1-09 Natural sciences and Mathematics - Pharmacy

ProBiS-Fold approach for binding site detection for whole structural human proteome in drug discovery

The ProBiS-Fold approach, on which the ProBiS-Fold web server is based, will enable for the first-time interactions between most human protein structures not limited to the Protein Data Base structures only, prediction of selectivity and ligand binding, and observation of conserved water effects and ligand binding sequence variants. This work will provide the scient...

01. October 2022 - 30. September 2025 | 1.07. Natural sciences and mathematics / Computer intensive methods and applications

Dynamical model of a type II DNA topoisomerase biological nanomachine and design of catalytic inhibitors

Cancer is one of the leading causes of death. The complex nature of cancer depends on genetic predispositions and environmental influences and poses a major challenge for treatment, as the efficiency of treatment depends on the specific response of each cancer tissue to a particular drug. The exploration of novel molecules that provide an efficient means to combat c...

01. October 2022 - 30. September 2025 | 1.04 Natural Sciences and mathematics/Chemistry